Jun 03, 2020 / 08:00PM GMT
Brandon Couillard - Jefferies LLC, Research Division - Equity Analyst
All right. Good afternoon. Welcome, everybody, to the Jefferies 2020 Virtual Global Healthcare Conference. I'm Brandon Couillard, I cover the life science tools in diagnostics sector here at the firm. Very happy to have Repligen with us back at the conference this year. Joining us for our conversation this afternoon, Mr. Tony Hunt, CEO; as well as Jon Snodgres, CFO. Thank you both for being here. I will say to anyone in the audience who's listening in, please feel free to e-mail me if you have any questions, and I'll do my best and let's try to work those in.
Questions and Answers:
Brandon Couillard - Jefferies LLC, Research Division - Equity AnalystSo maybe let's -- if we can just jump right into it, Tony, if think about the bioprocessing industry at a high level, about a $10 billion market, growing sort of high single digits. You've been growing double that rate organically for quite some time, did 33% last year. What are some of the key factors to think about in terms of your ability
Trustpilot
